This followed the active pharmaceutical ingredient (API) manufacturer's strong earnings print in Q4FY24.
The pharma firm's stock ended the day with gains of 3.2 per cent at ₹4,222 a share.
While analysts said they were positive about the firm's performance and its FY25 commentary, they said the stock price might see some downsides amid rich valuation.
The March quarter of FY24 saw the company's net profit rise 67 per cent to ₹538 crore compared to ₹321 crore in the corresponding period last year. Its revenue grew 18 per cent to 2,303 crore.
Esta historia es de la edición May 28, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición May 28, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
In the shadow of the mighty Annapurna
The unusual charm of trekking to Mardi Himal in the rainy season
Govt to organise Global IndiaAl Summit on July 3-4
The Ministry of Electronics and Information Technology will organise a global AI summit on July 3-4 to discuss issues related to artificial intelligence with India firmly committed to ethical and inclusive growth of this new-age technology.
ON THE BOIL
Why are milk prices rising when the supply is healthy?
Asset monetisation helped RIL create value: Morgan Stanley
Asset monetisation cycles have created 2-3x value for the shareholders of Reliance Industries in the last three decades, with each decade witnessing $60 billion in market cap creation, according to a report by the US-based financial services firm Morgan Stanley.
Weak steel prices rob metal sector's sheen
Slowdown in mining activity due to monsoon season will continue to remain a challenge in near-term, say analysts
MF Lite norms proposed for passive AMCs
The Securities and Exchange Board of India (Sebi) on Monday proposed to introduce a lighter version of mutual fund (MF) regulations for 'passive only' fund houses.
Clear skies ahead: Strong long-term gains for IndiGo
Long-term macro trends indicate growth in demand for air travel.
Regulator directs exchanges, other MIIs to levy same fees
The Securities and Exchange Board of India (Sebi) on Monday directed stock exchanges and other market infrastructure institutions (MIIs) to discontinue with the practice of levying slab-wise fee structures.
Niva Bupa files draft papers for ₹3,000 cr IPO
Niva Bupa Health Insurance has filed a draft red herring prospectus (DRHP) with the capital market regulator Securities and Exchange Board of India (Sebi) to raise ₹3,000 crore via initial public offering (IPO).
Mkts start July on strong note, log new highs
Indian equities extended their winning run during the first session of July by logging new highs on Monday, supported by gains in banking and technology stocks.
